Grant of Director Share Options

AI SummaryClose X

Thalia Therapeutics plc has granted options over 200,000,000 ordinary shares to five directors at an exercise price of 0.6 pence per share, aligning director incentives with shareholder interests following a recent acquisition. These options have a ten-year term, with 50% vesting based on continued employment and the remaining 50% contingent on the company's share price reaching 1.2 pence and 1.8 pence. The granted options represent approximately 11.25% of the current issued share capital and around 7.5% on a fully diluted basis.

Disclaimer*

UK 100

Latest directors dealings